Case number 1:22-cv-01431
Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 22, 2024 | 26 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 01/22/2024) (4) |
| Jan 17, 2024 | 25 | STIPULATION of Dismissal Without Prejudice by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 01/17/2024) (2) |
| Jan 2, 2024 | 24 | STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to - filed by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 01/02/2024) (3) |
| Dec 7, 2023 | 23 | STIPULATION TO EXTEND TIME Certain Scheduling Order Deadlines to - filed by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 12/07/2023) (3) |
| Nov 21, 2023 | 22 | STIPULATION TO EXTEND TIME Certain Scheduling Order Deadlines to - filed by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 11/21/2023) (3) |
| Nov 2, 2023 | 21 | STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to - filed by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 11/02/2023) (2) |
| Oct 18, 2023 | 20 | STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to - filed by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 10/18/2023) (2) |
| Oct 5, 2023 | 19 | Joint STIPULATION and Proposed Order for Extension of Certain Scheduling Order Deadlines re 16 SO ORDERED,, Set/Reset Deadlines for Claim Construction Briefing,, Set/Reset Scheduling Order Deadlines, by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 10/05/2023) (2) |
| Sep 11, 2023 | 17 | NOTICE OF SERVICE of Plaintiff Supernus Pharmaceuticals, Inc.'s Identification of Accused Products and Asserted Patents; Supernus Pharmaceuticals, Inc.'s Initial Disclosures to Defendant Under Fed. R. Civ. P. 26(a)(1); Supernus's Initial Disclosures Pursuant to Para. 3 of the Default Standard for Discovery filed by Supernus Pharmaceuticals, Inc..(DiGiovanni, Francis) (Entered: 09/11/2023) (2) |
| Sep 11, 2023 | 18 | NOTICE OF SERVICE of (1) Defendant Ajanta Pharma Limiteds Rule 26(a)(1) and (2) Defendant Ajanta Pharma Limiteds Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Ajanta Pharma Limited.(Stamoulis, Stamatios) (Entered: 09/11/2023) (2) |
| Aug 14, 2023 | 16 | SO ORDERED, re 15 Joint STIPULATION and Proposed Order Amending Scheduling Order re 13 Scheduling Order -- Joint Claim Construction Brief due by 6/7/2024. The Markman Hearing is continued to 6/26/2024 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. Fact Discovery completed by 7/25/2024 (See Stipulation for additional deadlines). Signed by Judge Gregory B. Williams on 8/14/2023. (etg) (Entered: 08/14/2023) (3) |
| Aug 8, 2023 | 15 | Joint STIPULATION and Proposed Order Amending Scheduling Order re 13 Scheduling Order,, by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 08/08/2023) (3) |
| Jul 19, 2023 | 14 | Joint PROPOSED ORDER Proposed Protective Order by Supernus Pharmaceuticals, Inc.. (Rahmeier, Thatcher) (Entered: 07/19/2023) (18) |
| Jul 13, 2023 | 13 | SCHEDULING ORDER: Fact Discovery completed by 5/1/2024. Status Report due by 12/15/2023. Joint Claim Construction Brief due by 1/31/2024. A Markman Hearing is set for 3/5/2024 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 2/5/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 2/10/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 7/13/23. (ntl) (Entered: 07/13/2023) (14) |
| Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Main Document) (2) |
| Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Appendix A, Proposed Patent Scheduling Order (ANDA)) (14) |
| Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Appendix B, Redline) (16) |
| Jan 24, 2023 | 11 | ANSWER to 8 Answer to Complaint, Counterclaim Supernus Pharmaceuticals, Inc.'s Answer to Defendant's Counterclaims by Supernus Pharmaceuticals, Inc..(DiGiovanni, Francis) (Entered: 01/24/2023) (30) |
| Jan 6, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, Corey Weinstein, and Kirby B. Drake - filed by Ajanta Pharma Limited. (Stamoulis, Stamatios) (Entered: 01/06/2023) (7) |
| Jan 3, 2023 | 8 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Ajanta Pharma Limited.(Stamoulis, Stamatios) (Entered: 01/03/2023) (30) |
| Jan 3, 2023 | 9 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Stamoulis, Stamatios) (Entered: 01/03/2023) (3) |
| Nov 16, 2022 | 7 | STIPULATION TO EXTEND TIME for Defendant to move, answer or otherwise respond to the Complaint to January 3, 2023 - filed by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 11/16/2022) (2) |
| Nov 4, 2022 | 6 | MOTION for Pro Hac Vice Appearance of Attorney Edward H. Haug, Nicholas F. Giove, Jason A. Kanter, Camile Y. Turner, and Anna N. Lukacher - filed by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 11/04/2022) (7) |
| Oct 28, 2022 | 1 | Complaint* (1) |
| Oct 28, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/31/2022) (3) |
| Oct 28, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/21/2022. Date of Expiration of Patent: 04/13/2027.Thirty Month Stay Deadline: 3/21/2025. (mpb) (Entered: 10/31/2022) (1) |
| Oct 28, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (mpb) (Entered: 10/31/2022) (2) |
| Oct 28, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Supernus Pharmaceuticals, Inc.. (mpb) (Entered: 10/31/2022) (2) |
